As reported to FSS/DART, 2025-12-31.
| Largest shareholder group | 9.75% |
|---|---|
| Minority shareholders | 91.29% |
| Top 10 holders | 9.75% |
| Total shareholders | 240,236 |
How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.
| Investor category | Holding % | Shareholders |
|---|---|---|
| Minority shareholders | 91.29% | 240,239 |
| Largest shareholder & related parties | 9.75% | — |
How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.
| S.No. | Shareholder | Shares | Stake % |
|---|---|---|---|
| 1 | 진양곤 | 9,497,926 | 7.16% |
| 2 | HLB생명과학 | 2,000,084 | 1.51% |
| 3 | HLB셀 | 748,197 | 0.56% |
| 4 | HLB글로벌 | 263,636 | 0.20% |
| 5 | 이현아 | 252,724 | 0.19% |
| 6 | 이현수 | 98,293 | 0.07% |
| 7 | HLB바이오스텝 | 58,215 | 0.04% |
| 8 | 진유림 | 9,012 | 0.01% |
| 9 | 진인혜 | 8,957 | 0.01% |
| 10 | 도순기 | — | 0.00% |
Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.